nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author Index
|
|
|
2005 |
1739 |
2-3 |
p. 355-356 2 p. |
artikel |
2 |
Can tau filaments be both physiologically beneficial and toxic?
|
King, Michelle E. |
|
2005 |
1739 |
2-3 |
p. 260-267 8 p. |
artikel |
3 |
Cultured cell and transgenic mouse models for tau pathology linked to β-amyloid
|
Bloom, George S. |
|
2005 |
1739 |
2-3 |
p. 116-124 9 p. |
artikel |
4 |
Cumulative Contents
|
|
|
2005 |
1739 |
2-3 |
p. 357-358 2 p. |
artikel |
5 |
Editorial board
|
|
|
2005 |
1739 |
2-3 |
p. ii- 1 p. |
artikel |
6 |
Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death
|
Feinstein, Stuart C. |
|
2005 |
1739 |
2-3 |
p. 268-279 12 p. |
artikel |
7 |
Modeling tauopathy: a range of complementary approaches
|
Hall, Garth F. |
|
2005 |
1739 |
2-3 |
p. 224-239 16 p. |
artikel |
8 |
Mutations causing neurodegenerative tauopathies
|
Goedert, Michel |
|
2005 |
1739 |
2-3 |
p. 240-250 11 p. |
artikel |
9 |
Pathways of tau fibrillization
|
Kuret, Jeff |
|
2005 |
1739 |
2-3 |
p. 167-178 12 p. |
artikel |
10 |
Phosphorylated tau and the neurodegenerative foldopathies
|
Kosik, Kenneth S. |
|
2005 |
1739 |
2-3 |
p. 298-310 13 p. |
artikel |
11 |
Pinning down phosphorylated tau and tauopathies
|
Lim, Jormay |
|
2005 |
1739 |
2-3 |
p. 311-322 12 p. |
artikel |
12 |
Potential structure/function relationships of predicted secondary structural elements of tau
|
Gamblin, T. Chris |
|
2005 |
1739 |
2-3 |
p. 140-149 10 p. |
artikel |
13 |
Preface
|
Bloom, George S. |
|
2005 |
1739 |
2-3 |
p. 89-90 2 p. |
artikel |
14 |
Recent advances in experimental modeling of the assembly of tau filaments
|
Ko, Li-wen |
|
2005 |
1739 |
2-3 |
p. 125-139 15 p. |
artikel |
15 |
Regulation of tau isoform expression and dementia
|
D'Souza, Ian |
|
2005 |
1739 |
2-3 |
p. 104-115 12 p. |
artikel |
16 |
Tau aggregation is driven by a transition from random coil to beta sheet structure
|
von Bergen, Martin |
|
2005 |
1739 |
2-3 |
p. 158-166 9 p. |
artikel |
17 |
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
|
Brandt, Roland |
|
2005 |
1739 |
2-3 |
p. 331-354 24 p. |
artikel |
18 |
Tau and src family tyrosine kinases
|
Lee, Gloria |
|
2005 |
1739 |
2-3 |
p. 323-330 8 p. |
artikel |
19 |
Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases
|
Andreadis, Athena |
|
2005 |
1739 |
2-3 |
p. 91-103 13 p. |
artikel |
20 |
Tau modifiers as therapeutic targets for Alzheimer's disease
|
Liu, Quan |
|
2005 |
1739 |
2-3 |
p. 211-215 5 p. |
artikel |
21 |
Tau pathology in Alzheimer disease and other tauopathies
|
Iqbal, Khalid |
|
2005 |
1739 |
2-3 |
p. 198-210 13 p. |
artikel |
22 |
Tau phosphorylation: physiological and pathological consequences
|
Stoothoff, William H. |
|
2005 |
1739 |
2-3 |
p. 280-297 18 p. |
artikel |
23 |
Tau protein as a differential biomarker of tauopathies
|
Sergeant, Nicolas |
|
2005 |
1739 |
2-3 |
p. 179-197 19 p. |
artikel |
24 |
Tau, tangles, and Alzheimer's disease
|
Binder, Lester I. |
|
2005 |
1739 |
2-3 |
p. 216-223 8 p. |
artikel |
25 |
Transcriptional and conformational changes of the tau molecule in Alzheimer's disease
|
Hyman, Bradley T. |
|
2005 |
1739 |
2-3 |
p. 150-157 8 p. |
artikel |
26 |
Transgenic animal models of tauopathies
|
Lee, Virginia M.-Y. |
|
2005 |
1739 |
2-3 |
p. 251-259 9 p. |
artikel |